Detalles de la búsqueda
1.
Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.
Ann Oncol
; 27(10): 1818-28, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27436850
2.
Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel.
Pharmacogenomics J
; 14(3): 248-55, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24061601
3.
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.
Ann Oncol
; 23(2): 427-35, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21525406
4.
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).
Ann Oncol
; 22(4): 827-834, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20880999
5.
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.
Breast Cancer Res Treat
; 128(2): 447-56, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21594665
6.
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.
Breast Cancer Res Treat
; 115(1): 87-99, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18483853
7.
Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone.
Oncology
; 76(3): 209-11, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19212145
8.
Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy.
Anticancer Res
; 29(2): 693-702, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19331224
9.
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Anticancer Res
; 29(2): 745-51, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19331231
10.
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
Ann Oncol
; 19(1): 115-22, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17938425
11.
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.
Ann Oncol
; 19(5): 853-60, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18042835
12.
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
Cancer Chemother Pharmacol
; 62(2): 277-84, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17901952
13.
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group.
Lung Cancer
; 58(3): 355-61, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17698241
14.
Weekly administration of topotecan-paclitaxel as second-line treatment in ovarian cancer.
Cancer Chemother Pharmacol
; 60(1): 123-8, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17111119
15.
Performance status (PS): a simple predictor of short-term outcome of cancer patients with solid tumors admitted to the intensive care unit (ICU).
Anticancer Res
; 27(4C): 2945-8, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17695475
16.
A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin.
Anticancer Res
; 27(6C): 4411-7, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18214053
17.
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
Anticancer Res
; 27(6C): 4391-5, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18214050
18.
Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients.
Lung Cancer
; 52(2): 225-33, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16567021
19.
Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study.
Cancer Chemother Pharmacol
; 57(6): 796-800, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16142488
20.
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.
J Clin Oncol
; 14(10): 2682-7, 1996 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-8874327